Fri0535 comparison of Serum Biomarkers for the Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: Clinical Significance of Serum Neopterin Levels

Abstract

BackgroundMacrophage activation syndrome (MAS) is a severe life-threatening condition that complicates systemic juvenile idiopathic arthritis (s-JIA). Differentiating MAS from these conditions is essential for selecting appropriate therapeutic interventions in a timely manner. However, there is no definite biomarkers that can effectively diagnose MAS.ObjectivesOur study aimed to compare the accuracy of serum biomarkers for the diagnosis of MAS complicating s-JIA and to investigate the clinical significance of serum neopterin levels as an indicator of disease activity and diagnosis of MAS complicating s-JIA.MethodsSerum cytokine levels (neopterin, IL-18, and CXCL9 and soluble tumor necrosis factor receptor type I (sTNFR-I) and II were determined by enzyme-linked immunosorbent assay in 78 patients with s-JIA, including 21 with MAS. The accuracy of these levels for the diagnosis of MAS were compared. Next, serum neopterin levels, in total 125 patients with s-JIA, including 30 with MAS, 15 with Epstein–Barr virus-induced hemophagocytic lymphohistiocytosis (EBV-HLH), and 15 with Kawasaki disease (KD), as well as 28 healthy controls (HCs) were analysed. Results were compared with the clinical features of MAS.ResultsReceiver operating characteristic curve analysis revealed area under the curve values and cut off values of neopterin, IL-18, CXCL9, sTNFR-II/I ratio and ferritin were 0.9465/19.5nmol/l, 0.8895/69250ng/ml, 0.9333/3130pg/ml, 0.9395/3.796 and 0.8671/2560ng/ml, respectively. Serum neopterin levels were significantly elevated in patients with MAS and EBV-HLH compared with those in patients with acute-phase s-JIA and KD. Serum neopterin levels profoundly and rapidly increased as MAS developed and correlated positively with disease activity.ConclusionSerum neopterin levels may be used as a promising indicator of disease activity in s-JIA and MAS and for evaluating it. It may also be a useful marker to diagnose the transition to MAS from active-phase s-JIA.References[1] Huber C, et al. J Exp Med1984;160:310-6.[2] Bracaglia C, et al. Ann Rheum Dis2017;76:166-72.[3] Shimizu M, et al. Clin Exp Immunol2018;191:349-355.Disclosure of InterestsNone declared

Fri0536 familial Mediterranean Fever (Fmf): A Single Centerexperience From Turkey

“…Although substantial progress had been achieved about the etiopathogenetic mechanisms of FMF during the past 20 years, the diagnosis is still based on clinical criteria. Objectives: To define the demographic, clinical and laboratory characteristics of children with FMF and then to compare the identification capacity of 3 validated FMF diagnostic criteria (Tel-Hashomer, Livneh and Pediatric) at our cohort (3)(4)(5). Methods: The medical records of 1685 children diagnosed and followed up as FMF were reviewed retrospectively.…”